MatrixSpace, a leader in portable AI-enabled radar for counter-UAS (C-UAS), announces the availability of its revolutionary Portable 360 ...

Evolver, a leader in defensive cybersecurity operations and digital transformation for U.S. Government agencies and Fortune 500 enterprises, today announced the launch of Evolver CLEAR (Cyber ...

Company advances JOTROL™ into Phase 2a Parkinson’s trial, launches Nugevia™ consumer brand, and strengthens financial positionJupiter, Florida, ...

Dire wolves, long confined to tar pits and fantasy epics, are suddenly being talked about as living, breathing animals again.

W hen Hemlock Grove premiered on Netflix in 2013, it arrived before streaming horror had truly found its footing. Coming just ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding South Dakota's life science and biotechnology research industry ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Enlivex Therapeutics is raising $212 million to invest in RAIN, the token of a blockchain-based prediction market, which will become its main treasury reserve asset.

Dec 10 (Reuters) - The U.S. House of Representatives on Wednesday passed a compromise version ‌of ​the 2026 National Defense ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the best gene-editing stocks to buy according to hedge funds. On November 5, Evercore ISI’s Gavin Clark-Gartner affirmed a Buy rating on Krystal Biotech, ...